You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment

Article metrics

Article menu

Download PDFPDF

Case Report
Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019550
Jan 2020661
Feb 2020553
Mar 202018182
Apr 2020774
May 202026266
Jun 202016160
Jul 2020202010
Aug 2020552
Sep 202023237
Oct 202018182
Nov 202018185
Dec 202015155
Jan 202112122
Feb 202111113
Mar 202118186
Apr 202114142
May 202112126
Jun 202112125
Jul 202112123
Aug 202110103
Sep 202117173
Oct 202117186
Nov 202117173
Dec 202118206
Jan 202210112
Feb 202217171
Mar 202220202
Apr 202217189
May 202233331
Jun 202229290
Jul 202220211
Aug 202232325
Sep 202226261
Oct 202230307
Nov 2022313311
Dec 202213130
Jan 202322222
Feb 202330310
Mar 202323242
Apr 202314142
May 202318183
Jun 2023880
Jul 202324247
Aug 2023990
Sep 202316162
Oct 2023995
Nov 202322224
Dec 2023252510
Jan 2024303110
Feb 202420208
Mar 2024282813
Apr 202418182
May 202460608
Jun 202426257
Jul 202438398
Aug 2024232111
Sep 2024141511
Oct 202421218
Nov 202427284
Dec 202415156
Jan 2025212111
Feb 202511711715
Mar 202531316
Apr 202526269
May 2025181830
Jun 202518187
Jul 2025110
Total14021413346